0001062993-24-004835.txt : 20240228
0001062993-24-004835.hdr.sgml : 20240228
20240228183838
ACCESSION NUMBER: 0001062993-24-004835
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240227
FILED AS OF DATE: 20240228
DATE AS OF CHANGE: 20240228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Crowley Michael
CENTRAL INDEX KEY: 0001629381
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-07928
FILM NUMBER: 24697851
MAIL ADDRESS:
STREET 1: 1000 ALFRED NOBEL DRIVE
CITY: HERCULES
STATE: CA
ZIP: 94547
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-RAD LABORATORIES, INC.
CENTRAL INDEX KEY: 0000012208
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 941381833
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 ALFRED NOBEL DRIVE
CITY: HERCULES
STATE: CA
ZIP: 94547
BUSINESS PHONE: 5107247000
MAIL ADDRESS:
STREET 1: 1000 ALFRED NOBEL DRIVE
CITY: HERCULES
STATE: CA
ZIP: 94547
FORMER COMPANY:
FORMER CONFORMED NAME: BIO RAD LABORATORIES INC
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2024-02-27
0000012208
BIO-RAD LABORATORIES, INC.
BIO BIOB
0001629381
Crowley Michael
C/O BIO-RAD LABORATORIES, INC.
1000 ALFRED NOBEL DRIVE
HERCULES
CA
94547
0
1
0
0
EVP, GBL Commercial Operations
0
Bio-Rad A Common Stock
2024-02-27
4
M
0
3000
215.98
A
9942.0000
D
Bio-Rad A Common Stock
2024-02-27
4
S
0
3000
336.00
D
6942.0000
D
Non-Qualified Stock Option (right to buy)
215.98
2024-02-27
4
M
0
3000
0
D
2027-09-05
Bio-Rad A Common Stock
3000
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.53 to $336.20, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 5, 2018, which was the first anniversary of the date on which the option was granted.
/s/ Michael Crowley
2024-02-28